The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent

Journal of Pharmaceutical and Biomedical Analysis
John R SogliaLeonard G Contillo

Abstract

An in vitro reactive intermediate screening assay, incorporating the use of the close analog of glutathione, glutathione ethyl ester (GSH-EE) as a conjugating agent, was developed to identify compounds that form reactive intermediates in an in vitro metabolite generating system. The biological assay consisted of substrate [s] = 10 microM, human liver microsomes, an NADPH generating system and glutathione ethyl ester. Conjugates were extracted from the biological matrix using a combination of protein precipitation and a semi-automated 96-well plate solid phase extraction (SPE) procedure. A micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry (microLC-microESI-MS/MS) method detected glutathione ethyl ester conjugates using selected reaction monitoring (SRM) to simultaneously monitor for multiple MH+ to [MH - 129]+ transitions, where the 129 mass unit (Da) represents the neutral loss of the pyroglutamate moiety from GSH-EE. The multiple MH+ to [MH - 129]+ transitions (SRM mass table) were generated for potential reactive intermediates of each compound. Glutathione (GSH) and GSH-EE conjugate standards were used to evaluate MS detection sensitivity. Based on direct comparison of standard curve data...Continue Reading

References

Aug 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M PirmohamedB K Park

❮ Previous
Next ❯

Citations

Jun 23, 2007·Analytical and Bioanalytical Chemistry·Roland F Staack, Gérard Hopfgartner
Oct 19, 2006·Pharmaceutical Research·Yuan ChenWilliam L Fitch
Oct 16, 2012·Journal of Medicinal Chemistry·Emily J HananJoseph P Lyssikatos
Aug 31, 2012·Chemical Research in Toxicology·Melanie Z SakatisStephen E Clarke
Apr 12, 2014·PLoS Pathogens·Hendrik Jan ThibautJohan Neyts
Dec 8, 2004·Drug Discovery Today·Alaa-Eldin F NassarCaroline Clarimont
Feb 25, 2009·Expert Opinion on Drug Metabolism & Toxicology·Bo Wen, William L Fitch
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Amit S Kalgutkar, John R Soglia
Nov 7, 2015·Journal of Applied Toxicology : JAT·Andreas Svennebring
May 26, 2015·Expert Opinion on Drug Metabolism & Toxicology·Mark P Grillo
Nov 21, 2014·Drug Metabolism Reviews·Deepak DalvieWeichao Chen
Nov 12, 2009·Journal of Pharmacological and Toxicological Methods·Masahiro MiuraIppei Nakagawa
Dec 23, 2015·Journal of Applied Toxicology : JAT·M José Gómez-LechónM Teresa Donato
Dec 9, 2008·Drug Discovery Today·Ari TolonenOlavi Pelkonen
Jul 22, 2005·Journal of Mass Spectrometry : JMS
Oct 24, 2012·Medicinal Research Reviews·Andrew V StachulskiMartin S Lennard
Aug 12, 2015·Journal of Pharmaceutical and Biomedical Analysis·Toni LassilaAri Tolonen
Oct 31, 2006·Drug Metabolism and Pharmacokinetics·Yasuhiro Masubuchi
May 1, 2009·Bioanalysis·Olavi PelkonenHannu Raunio
Sep 29, 2011·Rapid Communications in Mass Spectrometry : RCM·Joanna E Barbara, Jose M Castro-Perez
Sep 13, 2006·Journal of Mass Spectrometry : JMS·Shuguang Ma, Raju Subramanian
Jun 20, 2007·Rapid Communications in Mass Spectrometry : RCM·Lekha SlenoGérard Hopfgartner
Mar 6, 2008·Rapid Communications in Mass Spectrometry : RCM·Mukesh K Mahajan, Christopher A Evans
Apr 4, 2007·Mass Spectrometry Reviews·Chandra PrakashAngus Nedderman
Jun 1, 2012·Worldviews on Evidence-based Nursing·Wendy A GiffordNancy Lefebre
Jan 26, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Deepak DalvieStephen Bowlin
Nov 4, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Amit S KalgutkarCornelis E C A Hop
Nov 8, 2020·Bioorganic & Medicinal Chemistry Letters·Christopher G ThomsonFlorence Zink
May 17, 2005·Chemical Research in Toxicology·Jinping GanW Griffith Humphreys

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here